Young- versus older-onset Parkinson's disease: Impact of disease and psychosocial consequences

Movement Disorders

Volumn 18, Issue 11, 2003, Pages 1250-1256

  Schrag, Anette ^a   Hovris, Anna ^a   Morley, David ^a   Quinn, Niall ^a   Jahanshahi, Marjan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Depression; Health related quality of life; Older onset; Parkinson's disease; Psychosocial impact; Young onset

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; DYSKINESIA; EMPLOYMENT; FAMILY LIFE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SELF REPORT; SOCIAL PSYCHOLOGY; SOCIAL STATUS; SOCIAL SUPPORT; SOCIOECONOMICS; STATISTICAL ANALYSIS;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; ADULT; AGE FACTORS; AGED; DEPRESSIVE DISORDER, MAJOR; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MARRIAGE; MIDDLE AGED; MOVEMENT DISORDERS; PARKINSON DISEASE; QUALITY OF LIFE; QUESTIONNAIRES; SELF CONCEPT; SEVERITY OF ILLNESS INDEX; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; STEREOTYPING;

EID: 1342347420     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10527     Document Type: Article

References (28)

1. Singer E. Premature social aging: the social-psychological consequences of a chronic illness. Soc Sci Med 1974;8:143-151.
2. Hobson P, Holden A, Meara J. Measuring the impact of Parkinson's disease with the Parkinson's Disease Quality of Life questionnaire. Age Ageing 1999;28:341-346.
3. Taba P, Asser T. Prevalence of Parkinson's disease in Estonia. Acta Neurol Scand 2002;106:276-281.
4. Fall PA, Axelson O, Fredriksson M, Hansson G, Lindvall B, Olsson JE, Granerus AK. Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community. J Clin Epidemiol 1996;49:637-641.
5. Kuopio AM, Marttila RJ, Helenius H, Rinne UK. Changing epidemiology of Parkinson's disease in southwestern Finland. Neurology 1999;52:302-308.
6. Hedrich K, Marder K, Harris J, Kann M, Lynch T, Meija-Santana H, Pramstaller PP, Schwinger E, Bressman SB, Fahn S, Klein C. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology 2002;58:1239-1246.
7. De La Fuente-Fernandez R, Lim AS, Sossi V, Adam MJ, Ruth TJ, Calne DB, Stoessl AJ, Lee CS. Age and severity of nigrostriatal damage at onset of Parkinson's disease. Synapse 2003;47:152-158.
8. Kostic VS, Filipovic SR, Lecic D, Momcilovic D, Sokic D, Sternic N. Effect of age at onset on frequency of depression in Parkinson's disease. J Neurol Neurosurg Psychiatry 1994;57:1265-1267.
9. Brown RG, MacCarthy B, Jahanshahi M, Marsden CD. Accuracy of self-reported disability in patients with parkinsonism. Arch Neurol 1989;46:955-959.
10. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998;245(Suppl.):10-14.
11. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
12. Schrag A, Selai C, Jahanshahi M, Quinn NP. The EQ-5D - a generic quality of life measure - is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2000;69:67-73.
13. Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 1984;40:1365-1367.
14. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893-897.
15. MacDonald LD, Anderson HR. Stigma in patients with rectal cancer: a community study. J Epidemiol Community Health 1984; 38:284-290.
16. Papathanasiou I, MacDonald L, Whurr R, Jahanshahi M. Perceived stigma in spasmodic torticollis. Mov Disord 2001;16:280-285.
17. Rosenberg M. Society and the adolescent self-image. Princeton, New Jersey: Princeton University Press;1967.
18. Folkman S, Lazarus RS. If it changes it must be a process: study of emotion and coping during three stages of a college examination. J Pers Soc Psychol 1985;48:150-170.
19. MacCarthy B, Brown R. Psychosocial factors in Parkinson's disease. Br J Clin Psychol 1989;28:41-52.
20. Jahanshahi M, Marsden CD. Personality in torticollis: a controlled study. Psychol Med 1988;18:375-387.
21. Sarason IG, Levine HM, Basham RB, Sarason BR. Assessing social support: the social support questionnaire. J Pers Soc Psychol 1983;44:127-139.
22. Schrag A, Ben-Shlomo Y, Brown R, Marsden CD, Quinn N. Young-onset Parkinson's disease revisited - clinical features, natural history, and mortality. Mov Disord 1998;13:885-894.
23. Kostic V, Przedborski S, Flaster E, Sternic N. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease. Neurology 1991;41:202-205.
24. Singer E. Social costs of Parkinson's disease. J Chronic Dis 1973; 26:243-254.
25. Jahanshahi M, Marsden CD. Living and coping with Parkinson's disease: a self-help guide for patients and their carers. London: Souvenir Press; 1998.
26. Giladi N, Treves TA, Paleacu D, et al. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. J Neural Transm 2000;107:59-71.
27. Wagner ML, Fedak MN, Sage JI, Mark MH. Complications of disease and therapy: a comparison of younger and older patients with Parkinson's disease. Ann Clin Lab Sci 1996;26:389-395.
28. Starkstein SE, Berthier ML, Bolduc PL, Preziosi TJ, Robinson RG. Depression in patients with early versus late onset of Parkinson's disease. Neurology 1989;39:1441-1445.